Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label follow-up of Accordion Pill Carbidopa/Levodopa in fluctuating Parkinson's disease
2015-003513-24Phase 3Terminated
- Sponsor
- Intec Pharma Ltd.
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of carbidopa + levodopa in Parkinson's disease (PD) and parkinsonism, sponsored by Intec Pharma Ltd. Primary endpoint: Change in UPDRS total score from baseline to Week 53. Started Mar 2016; status: terminated.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)parkinsonism
Beyond the preview
Go deeper on 2015-003513-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003513-24.